Compile Data Set for Download or QSAR
maximum 50k data
Found 2435 with Last Name = 'ujjainwalla' and Initial = 'f'
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468144(CHEMBL4286244)
Affinity DataIC50:  0.100nMAssay Description:Antagonist activity at human SSR5 expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 15 mins fol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123235(US8742110, 3-20)
Affinity DataIC50:  0.129nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123247(US8742110, 4-11)
Affinity DataIC50:  0.152nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123253(US8742110, 4-17)
Affinity DataIC50:  0.165nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123270(US8742110, 5-6)
Affinity DataIC50:  0.172nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuropeptides B/W receptor type 1(Mus musculus)
Merck

Curated by ChEMBL
LigandPNGBDBM50362418(CHEMBL1938418)
Affinity DataIC50:  0.180nMAssay Description:Displacement of [125]-hNPW23 from mouse NPBWR1 expressed in CHO-K1 cells membrane by scintillation proximity assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123248(US8742110, 4-12)
Affinity DataIC50:  0.188nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuropeptides B/W receptor type 1(Mus musculus)
Merck

Curated by ChEMBL
LigandPNGBDBM50362419(CHEMBL1940544)
Affinity DataIC50:  0.200nMAssay Description:Displacement of [125]-hNPW23 from mouse NPBWR1 expressed in CHO-K1 cells membrane by scintillation proximity assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468160(CHEMBL4293458)
Affinity DataIC50:  0.200nMAssay Description:Displacement of [3-125I-Tyr11]-SRIF-14 or [3-125I-Tyr11]-SRIF-28 from human SSR5 expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468136(CHEMBL4287248)
Affinity DataIC50:  0.200nMAssay Description:Displacement of [3-125I-Tyr11]-SRIF-14 or [3-125I-Tyr11]-SRIF-28 from human SSR5 expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50249076(CHEMBL4096914)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123300(US8742110, 6-18)
Affinity DataIC50:  0.225nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123254(US8742110, 4-18)
Affinity DataIC50:  0.228nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123271(US8742110, 5-7)
Affinity DataIC50:  0.233nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123255(US8742110, 4-19)
Affinity DataIC50:  0.243nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123296(US8742110, 6-14)
Affinity DataIC50:  0.260nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123252(US8742110, 4-16)
Affinity DataIC50:  0.272nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468144(CHEMBL4286244)
Affinity DataIC50:  0.300nMAssay Description:Displacement of [3-125I-Tyr11]-SRIF-14 or [3-125I-Tyr11]-SRIF-28 from human SSR5 expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Mus musculus)
Merck

Curated by ChEMBL
LigandPNGBDBM123216(US8742110, 3-1)
Affinity DataIC50:  0.300nMAssay Description:Antagonist activity at mouse SSR5 expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 15 mins fol...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50249075(CHEMBL4069720)
Affinity DataIC50:  0.300nMAssay Description:Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123277(US8742110, 5-13)
Affinity DataIC50:  0.317nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123227(US8742110, 3-12)
Affinity DataIC50:  0.323nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuropeptides B/W receptor type 1(Mus musculus)
Merck

Curated by ChEMBL
LigandPNGBDBM50362420(CHEMBL1940540)
Affinity DataIC50:  0.330nMAssay Description:Displacement of [125]-hNPW23 from mouse NPBWR1 expressed in CHO-K1 cells membrane by scintillation proximity assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123306(US8742110, 6-24)
Affinity DataIC50:  0.342nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123234(US8742110, 3-19)
Affinity DataIC50:  0.359nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123264(US8742110, 4-28)
Affinity DataIC50:  0.395nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123257(US8742110, 4-21)
Affinity DataIC50:  0.397nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468146(CHEMBL4285917)
Affinity DataIC50:  0.400nMAssay Description:Antagonist activity at human SSR5 expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 15 mins fol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468157(CHEMBL4289661)
Affinity DataIC50:  0.400nMAssay Description:Antagonist activity at human SSR5 expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 15 mins fol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468157(CHEMBL4289661)
Affinity DataIC50:  0.400nMAssay Description:Displacement of [3-125I-Tyr11]-SRIF-14 or [3-125I-Tyr11]-SRIF-28 from human SSR5 expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468136(CHEMBL4287248)
Affinity DataIC50:  0.400nMAssay Description:Antagonist activity at human SSR5 expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 15 mins fol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123250(US8742110, 4-14)
Affinity DataIC50:  0.407nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123243(US8742110, 4-7)
Affinity DataIC50:  0.409nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuropeptides B/W receptor type 1(Mus musculus)
Merck

Curated by ChEMBL
LigandPNGBDBM50362417(CHEMBL1940545)
Affinity DataIC50:  0.420nMAssay Description:Displacement of [125]-hNPW23 from mouse NPBWR1 expressed in CHO-K1 cells membrane by scintillation proximity assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123179(US8742110, 1-28)
Affinity DataIC50:  0.421nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123272(US8742110, 5-8)
Affinity DataIC50:  0.424nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuropeptides B/W receptor type 1(Mus musculus)
Merck

Curated by ChEMBL
LigandPNGBDBM50362409(CHEMBL1940543)
Affinity DataIC50:  0.430nMAssay Description:Displacement of [125]-hNPW23 from mouse NPBWR1 expressed in CHO-K1 cells membrane by scintillation proximity assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123236(US8742110, 3-21)
Affinity DataIC50:  0.437nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123245(US8742110, 4-9)
Affinity DataIC50:  0.439nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50098391((S)-4-(2-(azetidin-2-yl)ethoxy)-7-chloro-2-oxo-N-(...)
Affinity DataIC50:  0.440nMAssay Description:In vitro inhibition of binding of the compound to GnRH receptor in humanMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123258(US8742110, 4-22)
Affinity DataIC50:  0.468nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123244(US8742110, 4-8)
Affinity DataIC50:  0.474nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123239(US8742110, 4-3)
Affinity DataIC50:  0.490nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50098391((S)-4-(2-(azetidin-2-yl)ethoxy)-7-chloro-2-oxo-N-(...)
Affinity DataIC50:  0.5nMAssay Description:In vitro inhibition of gonadotropin-releasing hormone receptor in rhesus monkeyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Rattus norvegicus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50373479(CHEMBL254757)
Affinity DataIC50:  0.5nMAssay Description:Binding affinity to rat MC4RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM50468160(CHEMBL4293458)
Affinity DataIC50:  0.5nMAssay Description:Antagonist activity at human SSR5 expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 15 mins fol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123240(US8742110, 4-4)
Affinity DataIC50:  0.502nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123242(US8742110, 4-6)
Affinity DataIC50:  0.546nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123307(US8742110, 6-25)
Affinity DataIC50:  0.550nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck

Curated by ChEMBL
LigandPNGBDBM123241(US8742110, 4-5)
Affinity DataIC50:  0.556nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 2435 total ) | Next | Last >>
Jump to: